tiprankstipranks
Trending News
More News >
Epigral Ltd (IN:EPIGRAL)
:EPIGRAL
India Market
Advertisement

Epigral Ltd (EPIGRAL) Price & Analysis

Compare
0 Followers

EPIGRAL Stock Chart & Stats

₹1698.50
-₹4.30(-0.24%)
At close: 4:00 PM EST
₹1698.50
-₹4.30(-0.24%)

EPIGRAL FAQ

What was Epigral Ltd’s price range in the past 12 months?
Epigral Ltd lowest stock price was ₹1506.60 and its highest was ₹2233.35 in the past 12 months.
    What is Epigral Ltd’s market cap?
    Epigral Ltd’s market cap is ₹73.28B.
      When is Epigral Ltd’s upcoming earnings report date?
      Epigral Ltd’s upcoming earnings report date is Nov 06, 2025 which is in 17 days.
        How were Epigral Ltd’s earnings last quarter?
        Epigral Ltd released its earnings results on Aug 02, 2025. The company reported ₹18.5 earnings per share for the quarter, beating the consensus estimate of ₹17.45 by ₹1.05.
          Is Epigral Ltd overvalued?
          According to Wall Street analysts Epigral Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Epigral Ltd pay dividends?
            Epigral Ltd pays a Semiannually dividend of ₹3.5 which represents an annual dividend yield of 0.35%. See more information on Epigral Ltd dividends here
              What is Epigral Ltd’s EPS estimate?
              Epigral Ltd’s EPS estimate is 14.1.
                How many shares outstanding does Epigral Ltd have?
                Epigral Ltd has 43,141,340 shares outstanding.
                  What happened to Epigral Ltd’s price movement after its last earnings report?
                  Epigral Ltd reported an EPS of ₹18.5 in its last earnings report, beating expectations of ₹17.45. Following the earnings report the stock price went up 0.788%.
                    Which hedge fund is a major shareholder of Epigral Ltd?
                    Currently, no hedge funds are holding shares in IN:EPIGRAL

                    Company Description

                    Epigral Ltd

                    Epigral Ltd (EPIGRAL) is a biotechnology company specializing in the development of innovative diagnostic and therapeutic solutions. Operating primarily within the healthcare sector, Epigral focuses on advancing personalized medicine through its cutting-edge technologies, which include molecular diagnostics and targeted therapies. The company's core products aim to improve patient outcomes by providing accurate disease detection and tailored treatment options.

                    Epigral Ltd (EPIGRAL) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Gufic Biosciences Limited
                    Marksans Pharma Limited
                    Shilpa Medicare Limited
                    Strides Pharma Science Ltd
                    Supriya Lifescience Limited
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis